IgG-Fc glycoengineering in non-mammalian expression hosts
about
Expression and glycoengineering of functionally active heteromultimeric IgM in plants.Generation and analysis of novel plant-derived antibody-based therapeutic molecules against West Nile virus.Protein production from the structural genomics perspective: achievements and future needs.Plant glyco-biotechnology on the way to synthetic biologyGeneration of biologically active multi-sialylated recombinant human EPOFc in plants.Oligomerization status influences subcellular deposition and glycosylation of recombinant butyrylcholinesterase in Nicotiana benthamiana.Glycoengineered Monoclonal Antibodies with Homogeneous Glycan (M3, G0, G2, and A2) Using a Chemoenzymatic Approach Have Different Affinities for FcγRIIIa and Variable Antibody-Dependent Cellular Cytotoxicity Activities.Processing of complex N-glycans in IgG Fc-region is affected by core fucosylationQuo vadis? The challenges of recombinant protein folding and secretion in Pichia pastoris.Glycosyltransferases: mechanisms and applications in natural product development.Engineering broadly neutralizing antibodies for HIV prevention and therapy.Accumulation of secreted antibodies in plant cell cultures varies according to the isotype, host species and culture conditions.Plant-produced anti-dengue virus monoclonal antibodies exhibit reduced antibody-dependent enhancement of infection activity.Structural and functional characterization of an anti-West Nile virus monoclonal antibody and its single-chain variant produced in glycoengineered plants.NMR-based structural validation of therapeutic antibody produced in Nicotiana benthamiana.An engineered diatom acting like a plasma cell secreting human IgG antibodies with high efficiency.Engineering of sialylated mucin-type O-glycosylation in plants.Expression of functionally active sialylated human erythropoietin in plantsN-Glycosylation of an IgG antibody secreted by Nicotiana tabacum BY-2 cells can be modulated through co-expression of human β-1,4-galactosyltransferase.
P2860
Q30412932-CDACA1F4-A49D-4629-B6CF-5778B1A636F6Q31154829-988EEBC0-0C14-4245-B010-9E8824A89550Q34174863-B714D923-B509-433D-BC3D-B997C487D6C9Q34304795-29315183-A5F0-48B0-BB3D-9C8D8AB094BEQ34571378-D31DF18C-501A-4D4A-929C-7140562D6158Q34693466-3E65A3DC-2C00-4554-91A9-534C343BD977Q35705039-8F1A1E01-4BB3-47B2-A787-B22292C98EA1Q36211489-436ADD64-05DF-4D01-BE94-68322D51364CQ38365726-2443A730-28CE-4076-853F-F126AABBC83FQ38578677-18CEE048-E2F0-40E5-8013-287EEC0F4969Q38717198-C72B614D-96FC-4796-8FC1-7147C6AE9464Q39039076-8D991E9A-7A9D-4BA3-A5B7-33F3CB53E7B2Q40078229-7172C38D-C54D-495F-AF79-0277FB94286DQ40201894-8AF1E106-8B94-405A-A5F1-49EB7D9B2F98Q41415137-7A5D7A35-197A-44E9-989C-FDD6400B48D2Q41694249-98DAEBB1-152C-4999-B792-3C17FEF6282BQ41770495-D16EB7A1-9961-483A-BD3F-2D783BCD31A6Q42229402-71FE41D1-990A-4981-931E-B20B8D6DF86DQ48089742-EF14FB80-ED50-498D-A030-B91318FB7BA3
P2860
IgG-Fc glycoengineering in non-mammalian expression hosts
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
IgG-Fc glycoengineering in non-mammalian expression hosts
@en
type
label
IgG-Fc glycoengineering in non-mammalian expression hosts
@en
prefLabel
IgG-Fc glycoengineering in non-mammalian expression hosts
@en
P2860
P921
P1476
IgG-Fc glycoengineering in non-mammalian expression hosts
@en
P2093
Andreas Loos
P2860
P304
P356
10.1016/J.ABB.2012.05.011
P407
P577
2012-05-23T00:00:00Z
2012-10-15T00:00:00Z